Queensland iAwards Nomination Recognises Innovation in Maternal Mental Health

Written By Ketim Technologies

Brisbane, Australia – July 14, 2025 – Ketim Technologies has been named a nominee for the Queensland iAwards, one of Australia’s most prestigious technology innovation programs. The recognition acknowledges the company’s pioneering work in developing biomarker-based, AI-powered diagnostics for the early detection of postpartum depression (PPD).

The iAwards celebrate innovations with the potential to create significant societal impact. Ketim Technologies’ nomination reflects the value of its mission — to deliver a clinical blood test capable of identifying a mother’s risk of PPD during pregnancy, enabling intervention months before symptoms appear.

The Queensland ceremony will take place tomorrow, with category winners advancing to the National iAwards later this year. Regardless of the outcome, the nomination underscores the growing recognition of Ketim Technologies’ role in advancing precision mental health care for women.

For media inquiries, please contact:
Dr. Clarissa Yates
CEO, Ketim Technologies
clarissa.yates@ketim.com.au

Ketim Technologies

https://www.ketim.com.au
Previous

Ketim Technologies Wins Queensland iAwards Start-Up Category
Next

Dried Blood Spot Collection to Revolutionise Postpartum Depression Screening